Edition:
United States

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

5.71USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$5.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,140
52-wk High
$17.76
52-wk Low
$5.48

Chart for

About

Cue Biopharma Inc is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes... (more)

Overall

Beta: --
Market Cap(Mil.): $122.41
Shares Outstanding(Mil.): 20.13
Dividend: --
Yield (%): --

Financials

  CUE.OQ Industry Sector
P/E (TTM): -- 79.62 29.34
EPS (TTM): -1.67 -- --
ROI: -104.60 -0.41 13.58
ROE: -104.60 -3.13 15.11

Earnings vs. Estimates